Search

everythinglearnresearchcommunity

for

Search:↓

Most patients with cutaneous dermatomyositis either improved or remained stable over 3.5 years.

Skin disease activity scores can help decide when skin symptoms no longer affect the quality of life in patients with mild dermatomyositis.

A 50-year-old woman with breast cancer developed an autoimmune skin disorder, highlighting the need for thorough checks and team-based treatment.

Scalp disease in dermatomyositis causes significant symptoms and has unique features.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

Up to half of people experience itchy scalp, often due to skin conditions like seborrheic dermatitis or psoriasis, and treatments vary based on the specific cause.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Apremilast shows promise for several skin conditions but needs more research.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Doctors should use a detailed patient history and physical exam to diagnose joint pain, and consult a rheumatologist early for suspected autoimmune diseases.

Cannabinoids may help some skin conditions but more research is needed.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

The conclusion is that differentiating wound types in RDEB patients is important for clinical trials and understanding the disease.

Hydroxychloroquine may cause false results in tuberculosis tests for patients with autoimmune skin diseases.

Psoriasis patients are willing to pay less than the cost of biologic treatments for remission and don't expect complete or long-term symptom clearance.

Watching, not removing, skin growths with moderate atypia and positive edges is okay; patients may get melanoma elsewhere, especially if they've had it before.

Platelet Rich Plasma can potentially help in restoring hair loss, but more research with larger groups is needed to confirm its effectiveness and standardize its use.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Using a teletriage system greatly increased access to skin care for uninsured Latino immigrants at a clinic.

Psoriasis patients experience moderate functional impairment related to disease severity and less satisfaction.

10% carbamide peroxide is safe and effectively reduces mild to moderate acne.

People with hidradenitis suppurativa who are more resilient tend to have better quality of life and less anxiety and depression.

Laser treatment may help with hair growth in some people with frontal fibrosing alopecia, but results vary and the exact way it works is unclear.

Papulopustular rosacea is an inflammatory skin condition treatable with lifestyle changes and medications.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.